- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/70 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 239/70
Total number of patents in this class: 512
10-year publication summary
|
44
|
24
|
28
|
34
|
28
|
25
|
16
|
32
|
8
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 3971 |
46 |
| Array BioPharma Inc. | 503 |
23 |
| Boehringer Ingelheim International GmbH | 4656 |
20 |
| Merck Sharp & Dohme LLC | 3750 |
15 |
| Duquesne University of the Holy Spirit | 126 |
12 |
| F. Hoffmann-La Roche AG | 7930 |
11 |
| Reata Pharmaceuticals, Inc. | 123 |
11 |
| PTC Therapeutics, Inc. | 483 |
10 |
| Bristol-myers Squibb Company | 4878 |
9 |
| Janssen Pharmaceutica N.V. | 3395 |
8 |
| Merck Sharp & Dohme Corp. | 2197 |
7 |
| Tetra Discovery Partners, LLC | 11 |
7 |
| Samsung SDI Co., Ltd. | 8276 |
6 |
| The Regents of the University of Michigan | 4693 |
6 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 642 |
6 |
| Hoffmann-La Roche Inc. | 3414 |
5 |
| Idemitsu Kosan Co., Ltd. | 4220 |
5 |
| ArQule, Inc. | 135 |
5 |
| Chimerix, Inc. | 89 |
5 |
| Duquesne University of the Holy Ghost | 29 |
5 |
| Other owners | 290 |